Latest News
QuantumScape Stock Rises on QSE-5 Production Start, Losses Persist
QuantumScape shares rose to $7.95 on initial production of its QSE-5 solid-state battery cells, but the company reported a Q1 net loss of $100.8 million with no revenue yet.
Alaska Air $500M Debt Sale Highlights War-Driven Fuel Cost Squeeze
Alaska Air Group issued $500M in senior notes to offset soaring jet fuel costs caused by the Iran war, joining American and JetBlue in tapping debt markets.
DoorDash Surges 10% on Strong Q2 Order Forecast Despite Profit Dip
DoorDash shares surged 10% on a Q2 order forecast beating estimates, even as Q1 net income slipped 5% to $184 million and revenue fell short of analyst expectations.
Axon Q1 Revenue Soars 34% on AI and Drone Demand, Guidance Raised
Axon Q1 revenue surged 34% to $807 million, beating estimates, as AI product revenue jumped over 700% and drone demand boosted outlook.
Snap Stock Falls 5% After Q1 Revenue Beat, Cautious Q2 Outlook, and End of Perplexity AI Deal
Snap Inc. reported Q1 revenue up 12% to $1.53B and 483M daily active users, but shares fell 5% after a cautious Q2 outlook and the end of the $400M Perplexity AI deal.
Coherent Stock Dips Despite Strong AI-Driven Q3 Results
Coherent Corp. shares dropped 6% after hours despite beating Q3 revenue estimates at $1.81B, driven by AI infrastructure demand. Wall Street focused on weak cash flow and margin misses.
AppLovin Shares Slide Despite Q1 Beat as Investors Eye Growth Sustainability
AppLovin reported Q1 revenue of $1.84B, up 59% YoY, and net income of $1.21B, more than doubling. Shares dropped 2.3% after hours as investors question long-term growth.
Loblaw Stock Dips 5% as Q1 Revenue Miss Overshadows Profit Growth
Loblaw reported Q1 revenue of C$14.48B, missing forecasts, sending shares down 5%. Net earnings rose to C$594M, and the company raised its dividend by 10% while approving a new buyback.
Beyond Meat Tops $1 Ahead of Q1 Results, Nasdaq Compliance in Focus
Beyond Meat shares reclaimed the $1 mark ahead of first-quarter earnings, but Nasdaq compliance pressure remains as the company faces a deadline to boost its stock price.
Compass Shares Surge 26% on Q1 Profit and Upbeat Q2 Forecast After Anywhere Deal
Compass Inc. shares surged 26% after reporting a first-quarter profit and issuing a strong second-quarter revenue forecast, boosted by its Anywhere Real Estate acquisition.
Bayer's $2.45B Perfuse Buy Aims to Revitalize Eye Drug Pipeline
Bayer acquires Perfuse Therapeutics for up to $2.45 billion to secure Phase II eye drug PER-001, aiming to bolster its ophthalmology unit as Eylea sales slip.